Business
Billionaire Hedge Fund Manager Michael Platt Invests in UK Biotech Firm Engitix
SOURCE:Bloomberg|BY:Manuel Baigorri
UK-based biotechnology company Engitix Ltd. has raised a further $25 million from billionaire Michael Platt to help develop its therapies for cancer and fibrosis.
Failed to fetch content: Request failed with error code 403